Cardiotoxicity
📧 Sign up to get email alerts when something new happens for Cardiotoxicity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Pilot Study of an NTproBNP Guided Strategy of Cardioprotection [Phase 1, Phase 2]
Pilot study results explore an NTproBNP-guided strategy to cardioprotection during chemotherapy in patients with cardiotoxicity risks.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy [NA]
This clinical trial update reports ongoing recruitment for a study using serial cardiac MRI with contrast agents and biomarker analysis to d…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial [NA]
This clinical trial assesses how different exercise intensities affect cardiac health in young adult survivors of childhood cancer, with no …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Artificial Intelligence for Reconstruction of Echocardiography Studies
An update on a clinical trial evaluating an artificial intelligence approach to reconstruct echocardiography studies for monitoring cardioto…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines [Phase 3]
Phase 3 trial evaluating empagliflozin to prevent anthracycline-induced cardiotoxicity in cancer patients; recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients
This completed clinical trial update describes methods for early detection of cardiotoxicity caused by systemic and radiation therapy in bre…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
A completed clinical study investigated whether aerobic exercise can modulate cardiotoxicity in long-term cancer survivors who were treated …
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
This feasibility study evaluates using patient similarity to support decision-making in preventing cardiovascular toxicity.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity [Phase 2]
A Phase 2 trial evaluated whether dapagliflozin can prevent anthracycline-induced cardiotoxicity. The study has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts. [NA]
A clinical trial evaluating a cardiovascular diagnostic for assessing risk of cardiotoxicity in patients with haemoblasts has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Prediction of Delayed Toxic Cardiomyopathy in Children [NA]
A pediatric trial evaluating prediction of delayed cardiomyopathy in children treated for cancer. The study status is TERMINATED.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy [NA]
This update describes a clinical trial evaluating aerobic exercise as a cardio-protective strategy for patients with hematologic cancers exp…
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity [Phase 3]
Phase 3 clinical trial assessing Shengmai San to prevent cardiac toxicity from sequential anthracycline and trastuzumab therapy in breast ca…
-
CLINICAL_TRIALS research · 2023-08-22Clinical Trial Update: Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) [Phase 4]
A Phase 4 trial evaluating whether spironolactone can prevent cardiotoxicity caused by anthracycline chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines [Phase 3]
Phase 3 trial evaluating nebivolol for cardioprotective effects during anthracycline chemotherapy in cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating prevention of chemotherapy-induced cardiotoxicity in children with bone tumors and acute myeloid leukemia has compl…
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study [Phase 2]
Phase 2 pilot study evaluating the use of statins for primary prevention of heart failure in patients receiving anthracycline therapy.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab [Phase 3]
Phase 3 clinical trial update addressing cardiotoxicity prevention in breast cancer patients treated with anthracyclines and/or trastuzumab.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Effect of Trimetazidine on Radiotherapy-induced Heart Damage. [Phase 2, Phase 3]
A clinical trial update evaluating the effect of trimetazidine on radiotherapy-induced heart damage in cardiotoxicity patients, with Phase 2…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Staccato Prochlorperazine Thorough QT/QTc [Phase 1]
Phase 1 thorough QT/QTc study of Staccato Prochlorperazine completed; results posted in 2019.